Similar Items: Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
- Next-Generation Sequence Detects ARAP3 as a Novel Oncogene in Papillary Thyroid Carcinoma [Retraction]
- Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
- Prognostic Significance of Pretreatment Mean Platelet Volume in Patients with Recurrent or De Novo Metastatic Breast Cancer: A Single-Center Retrospective Study
- Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
- HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
- Risk of venous thromboembolism with CDK4/6 inhibitor use in breast cancer: a systematic review and meta-analysis